Hepatitis C Therapy - Maxygen Announces Achievement of Milestone in Roche Alliance

Maxygen Announces Achievement of Milestone in Roche Alliance
PharmaLive.com (press release), PA - Dec 14, 2005... We believe our next generation interferon alpha program has the potential to become a cornerstone of future hepatitis C therapy and we are confident that Roche ...

Higher doses of pegylated interferon or ribavirin improve ...
Aidsmap, UK - Dec 8, 2005Given that standard hepatitis C therapy with pegylated interferon plus ribavirin produces a sustained virological response (SVR) in less than 50% in patients ...

Vertex hepatitis C drug gets fast track
BusinessWeek - Dec 8, 20058 9:40 AM ET Vertex Pharmaceuticals Inc. said Thursday that it received a "fast track" designation from regulators for a hepatitis C therapy it is developing. ...

SciClone Reports Results From First ZADAXIN Phase 3 Hepatitis C ...
Market Wire (press release) - Dec 14, 2005... trial results to determine and coordinate with Sigma-Tau, our European collaborator, the next steps regarding the development of ZADAXIN in hepatitis C therapy ...